Our stories

We are patients, we are donors, we are a community, we are humans.

Discover all stories
Projects
Affianco – A joint narrative of Primary Immunedeficiencies
Watch
People
Diane’s story: a long journey to a Primary Immunedeficiencies diagnosis
Watch
Projects
SIDE BY SIDE 2.0: the power of mutual support
Read
Events
ESID and GPM 2024: amplifying the voices of the PID community
Read
NEWS

Discover our press releases, media resources, event information and stay updated on the latest news.

Kedrion Biopharma receives FDA approval for QIVIGY® and confirms its plan to increase investments in the US throughout its global operations 29-09-2025 Kedrion Biopharma receives FDA approval for QIVIGY® and confirms its plan to increase investments in the US throughout its global operations Read the news
FDA grants Orphan Drug Designation to investigational plasma-derived treatment for Congenital Aceruloplasminemia  07-08-2025 FDA grants Orphan Drug Designation to investigational plasma-derived treatment for Congenital Aceruloplasminemia  Read the news
A new standard in Social Responsibility: PAS 24000 achieved 31-07-2025 A new standard in Social Responsibility: PAS 24000 achieved Read the news
2024 Annual Report - Connections that transform
Discover Kedrion’s 2024 journey through an immersive digital experience.

From global growth to human stories, from innovation to impact – this is not just a Report, it’s a new way to connect.

👉 Explore the Report!
Read more
The 2024 Sustainability Report is here!
Discover how we are making strides in sustainability and creating rare connections that impact millions of lives. Learn about our efforts in reducing our carbon footprint, conserving water, and fostering diversity and innovation.

Click "read more" to explore our journey and achievements.
Read more
shield (1)
Pharmacovigilance
genetics (1)
Medical & Scientific Information